These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 6487349)

  • 1. Nonenzymatic glucosylation of human serum albumin and its influence on binding capacity of sulfonylureas.
    Tsuchiya S; Sakurai T; Sekiguchi S
    Biochem Pharmacol; 1984 Oct; 33(19):2967-71. PubMed ID: 6487349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chromatographic analysis of acetohexamide binding to glycated human serum albumin.
    Joseph KS; Anguizola J; Jackson AJ; Hage DS
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Oct; 878(28):2775-81. PubMed ID: 20829128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Binding of tolbutamide to glycated human serum albumin.
    Joseph KS; Anguizola J; Hage DS
    J Pharm Biomed Anal; 2011 Jan; 54(2):426-32. PubMed ID: 20880646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucosylated albumin and its influence on salicylate binding.
    Mereish KA; Rosenberg H; Cobby J
    J Pharm Sci; 1982 Feb; 71(2):235-8. PubMed ID: 7062252
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies of binding by sulfonylureas with glyoxal- and methylglyoxal-modified albumin by immunoextraction using affinity microcolumns.
    Rodriguez EL; Tao P; Woolfork AG; Li Z; Matsuda R; Sun Z; Hage DS
    J Chromatogr A; 2021 Feb; 1638():461683. PubMed ID: 33223150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of tolazamide binding with glycated and normal human serum albumin by using high-performance affinity chromatography.
    Tao P; Li Z; Woolfork AG; Hage DS
    J Pharm Biomed Anal; 2019 Mar; 166():273-280. PubMed ID: 30682693
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chromatographic studies of changes in binding of sulfonylurea drugs to human serum albumin due to glycation and fatty acids.
    Basiaga SB; Hage DS
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Nov; 878(30):3193-7. PubMed ID: 20974553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Analysis of multi-site drug-protein interactions by high-performance affinity chromatography: Binding by glimepiride to normal or glycated human serum albumin.
    Matsuda R; Li Z; Zheng X; Hage DS
    J Chromatogr A; 2015 Aug; 1408():133-44. PubMed ID: 26189669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unveiling the molecular mechanisms underpinning biorecognition of early-glycated human serum albumin and receptor for advanced glycation end products.
    Tramarin A; Naldi M; Degani G; Lupu L; Wiegand P; Mazzolari A; Altomare A; Aldini G; Popolo L; Vistoli G; Przybylski M; Bartolini M
    Anal Bioanal Chem; 2020 Jul; 412(18):4245-4259. PubMed ID: 32367292
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chromatographic studies of chlorpropamide interactions with normal and glycated human serum albumin based on affinity microcolumns.
    Tao P; Li Z; Matsuda R; Hage DS
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Oct; 1097-1098():64-73. PubMed ID: 30205233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Review: Glycation of human serum albumin.
    Anguizola J; Matsuda R; Barnaby OS; Hoy KS; Wa C; DeBolt E; Koke M; Hage DS
    Clin Chim Acta; 2013 Oct; 425():64-76. PubMed ID: 23891854
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of free drug fractions by ultrafast affinity extraction: interactions of sulfonylurea drugs with normal or glycated human serum albumin.
    Zheng X; Matsuda R; Hage DS
    J Chromatogr A; 2014 Dec; 1371():82-9. PubMed ID: 25456590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of non-enzymatic glycation in human serum albumin. Spectroscopic analysis.
    Szkudlarek A; Sułkowska A; Maciążek-Jurczyk M; Chudzik M; Równicka-Zubik J
    Spectrochim Acta A Mol Biomol Spectrosc; 2016 Jan; 152():645-53. PubMed ID: 25735846
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonenzymatic glycosylation of human serum albumin and its effect on antibodies profile in patients with diabetes mellitus.
    Raghav A; Ahmad J; Alam K
    PLoS One; 2017; 12(5):e0176970. PubMed ID: 28520799
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The pharmacology of sulfonylureas.
    Skillman TG; Feldman JM
    Am J Med; 1981 Feb; 70(2):361-72. PubMed ID: 6781341
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characterization of the binding of sulfonylurea drugs to HSA by high-performance affinity chromatography.
    Joseph KS; Hage DS
    J Chromatogr B Analyt Technol Biomed Life Sci; 2010 Jun; 878(19):1590-8. PubMed ID: 20435530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding studies based on ultrafast affinity extraction and single- or two-column systems: Interactions of second- and third-generation sulfonylurea drugs with normal or glycated human serum albumin.
    Yang B; Zheng X; Hage DS
    J Chromatogr B Analyt Technol Biomed Life Sci; 2018 Dec; 1102-1103():8-16. PubMed ID: 30366211
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of glycosylation of hypoglycaemic drug binding to serum albumin.
    Koyama H; Sugioka N; Uno A; Mori S; Nakajima K
    Biopharm Drug Dispos; 1997 Dec; 18(9):791-801. PubMed ID: 9429743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Temperature on Tolbutamide Binding to Glycated Serum Albumin.
    Szkudlarek A; Pentak D; Ploch A; Pożycka J; Maciążek-Jurczyk M
    Molecules; 2017 Mar; 22(4):. PubMed ID: 28362348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of glycation on the binding of human serum albumin to warfarin and L-tryptophan.
    Joseph KS; Hage DS
    J Pharm Biomed Anal; 2010 Nov; 53(3):811-8. PubMed ID: 20537832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.